Thermal analysis methods and coupled techniques are well established procedures in material science. Due to the different information delivered, thermal analysis methods are concurrent or complementary to other analytical techniques such as spectroscopy, chromatography, melting point determination, loss on drying, assay, for identification, purity and quantitation. They are basic methods in the field of polymer analysis and in physical and chemical characterisation of pure substances as well as for mixtures. They find best application for pre-formulation, processing and control of the drug product.
The introduction of sophisticated, automated, robust and sensitive instruments considerably increases the advantages of these methods. New horizons are open with the availability of combined techniques and microcalorimetry, an emerging technique now used routinely.
Since change of temperature and moisture occur by processing and storage, changes of the solid state may have a considerable effect on activity, toxicity and stability of compounds. Pharmaceutical industry is faced with the new challenges of quicker development and higher performance in terms of technology, reliability and up-scale in an international cGMP environment. Current requirements of the International Conference of Harmonisation for the characterisation and the quantitation of polymorphism in new entities1 re-enforce the position of thermal analysis and microcalorimetric techniques which can deliver the right information for the thermodynamic relationships between phases for the proper selection of salt and crystal form. The amorphous state is better understood and determinable. DSC purity analysis is a fast absolute orthogonal purity technique for organic compounds. Stability screening with microcalorimetry, phase diagrams for interaction with excipients enable the drug product to be designed.
What are the thermal analysis and calorimetric techniques?
When a material is heated or cooled, there is a change in its structure or composition. These transformations are connected with a heat exchange. The first method developed by Le Chatelier in 18872 was differential thermal analysis (DTA) where only the temperature induced in the sample was measured. Differential scanning calorimetry (DSC) which determines the heat flow into and out of the sample as well as the temperature of the thermal phenomenon during a controlled change of temperature is the basic thermal technique used for the industry. A typical DSC scan of an organic compound is exemplified in Figure 1.
This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.
Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.
What you’ll discover:
Key trends shaping the pharmaceutical formulation sector
Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
Thermal analysis techniques cover all techniques in which a physical property is monitored as a function of temperature or time while the sample is heated or cooled under controlled conditions. Table 1 summarises most methods covered including coupled and combined techniques.
Books or review articles dealing with the principle and instrumentation are given in References 3-6 and applications of thermal analysis methods for pharmaceuticals focused on industry are given in 7-20.
What are the areas of application?
Table 2 summarises the main features of the methods and the huge areas of applications.
Thermal analysis and development
Manufacturing of pharmaceuticals generally implies two separated steps: manufacturing the active molecule (active pharmaceutical ingredient or drug substance) and manufacturing the formulation (dosage form or drug product) which is given to the patient. The formulation itself plays a decisive role for the action in the body, e.g. quick action, long action, site of action. According to the medical needs, the medicament can be applied orally as a tablet, a capsule, a syrup, a solution, or intramusculary or parenterally as injection, suppository, cream, gel, nasal spray or inhalation. Special delivery systems such as depot forms, minipumps and patches allow constant delivery for patients without the needs to be in hospitals. These formulations require auxiliary substances called excipients and adapted technologies for the manufacture of the drug product. For the patient it is mandatory that the product remains identical batch to batch and throughout its shelf-life in order to maintain the action at the desired time without unexpected side effects.
For mixtures of several components, the phase diagrams rules should be considered. If there is no interaction between two compounds in the solid state and miscibility of the liquid state, a eutectic behavior will be observed during heating of the mixture. This behaviour is the basis of the purity analysis by DSC and of the study of chiral purifications. If there is no interaction in the solid state and no miscibility in the liquid state, the DSC scan of the mixture of two compounds will be the addition of the two DSC scans. This is the basis of quantitation of components in the drug product. An interaction in the solid state may result from the formation of solid-solution with partial or total miscibility, from the formation of complex, or from chemical reaction. Pharmaceuticals may also be studied in aqueous media in order to follow, for example, protein denaturation, gel formation, liposome formation or in order to design the conditions of lyophilization.
Figure 3 summarises the development steps- design, process and product- and the area of interest for the use of these techniques. The objectives are achieved by the proper choice of the salt form21, of the polymorphic form22-25, the control of the drug substance and of the excipients whatever their provenience as well as by the monitoring of the processing and the storage of the drug product.
Figure 3 is an example of rational use of combined techniques for a proper and quick interpretation of thermal events. The DSC curve of a malonate salt would lead to the conclusion of a dual melting typical for polymorphism. After melting, malonic acid is decomposed and the drug substance recrystallises as base.
Thermodynamic and kinetic
The processing of the drug substances and drug products involve solvent(s), temperature and pressure changes as well as mechanical stress and different solid phases may coexist in the drug product. Organic substances show supersaturation behaviour and unstable solid phases which should not exist in defined temperature, pressure and humidity may behave like stable forms. These solid metastable phases obtained outside their domains of stability will convert to the thermodynamic stable forms at given temperatures, pressures and relative humidities in response to changes in environmental conditions, processing or over time. These conversions driven by thermodynamics are governed by kinetic and are influenced by impurities, particle size, crystal defects and presence of seeds.
The market withdrawal of ritonavir in 1998 – one year after its launch – was caused by its far too slow dissolution rate due to an insoluble stable polymorph not found during development. The current focus of research in the solid-state area is to understand the origin of polymorphism at the molecular level and to predict and prepare at the beginning of development the most stable form. The selection of a metastable form should result from targeted choice, not from the hazard. Thermal analysis techniques deliver basic thermodynamic rules for polymorphism22,23. The advantage of thermal and microcalorimetric techniques for their sensitivity allow the need to be significantly less than the 1 mg amount. For strategy of development and quantitation in drug substance and drug product, see references 23-25.
Combined thermal analysis techniques
Figure 4 shows an example of polymorphism study for the relationships between all phases.
DSC Purity analysis
The method27 is especially attractive since it does not need a reference standard. The method delivers absolute purity or assay value. Results are obtained in less than 30 minutes.
DSC purity analysis allows the following:
Optimisation of analytical stability indicative methods for drug substance
Comparison of the quality of suppliers
Optimisation of purification
Comparison of methods for changes in synthesis
Support results of routine batch analysis and stability studies
Additional qualification of reference standards28
Study of the amorphous state
The use of amorphous forms is attractive, particularly for sparingly soluble compounds owing to the enhanced solubility and dissolution rate over the crystalline state, leading to increased bioavailability. Amorphous additives or excipients can give miscible phases with a new temperature of glass transition higher than the drug substance with the ability to stabilise it in the amorphous state. However, the amorphous state is thermodynamically unstable. The glass transition temperature, Tg, is lowered by water or other additives facilitating conversion to the rubbery state and hence facilitating crystallisation. Hancock and Zografi studied intensively the amorphous state of drug substances and used the relaxation energy at the glass transition as well as the dependency of the heating rate for the study of the ‘fragility’ of the amorphous state29. Stabilisation strategies have been researched30. More recently, Thermally Stimulated Depolarization Current (TSC) proved to be very sensitive for detection of the rigid fractions of the amorphous drugs and is used for the study of relaxation transitions alpha and beta31.
Microcalorimetry
Microcalorimetry is a growing technique32-38 complementary to DSC for the characterisation of pharmaceuticals. Larger sample volume and high sensitivity means that phenomena of very low energy (unmesurable by DSC) may be studied. The output of the instrument is measured by the rate of heat change (dq/dt) as a function of time with a high sensitivity better than 0.1 μW. Microcalorimetry can be applied to isolated systems in specific atmospheres; or for batch mode where reactants are mixed in the calorimeter. Solution calorimetry can be used in adiabatic or isoperibol modes in microcalorimeters at constant temperature. The method is used for polymorphic interpretation and for quantitation23. Microcalorimetry is useful for stability and compatibility predictions33-35.
The most useful application nowadays, thanks to high throughput microcalorimeters38, is the routine quantitation of amorphous content down to 0.1-0.3% when undesirable32-34,36-38,25.
References
International Conference on Harmonization (ICH) (1999) Guideline Specification Q6A, Decision Tree: Investigating the need to set acceptance criteria for polymorphism in drug substances and drug products
L. Le Chatelier, Compt. Rend., 104 , 1886. 1243.
W.W.Wendlandt, Thermal Analysis, 3 rd Ed.. In Chemical Analysis ; Vol. 19., P. J.Elving, J. D.Winefordner, I. M Kolthoff, Eds ; John Wiley, New York, 1986.
B. Wunderlich, Thermal Analysis, Academic Press, New York, 1990.
P. J.Haines, Thermal Methods of Analysis, Principles, Applications and Problems, Blackie, Academic Professional, 1995.
E.A. Turi, Thermal Characterization on Polymeric Materials ; 2nd Ed. ; Academic Press, New York, 1997.
J.L. Ford and P. Timmins, Pharmaceutical Thermal Analysis Techniques and Applications, Ellis Horwood Books in Biological Sciences, Series in Pharmaceutical Technology, Rubinstein M.H., Ed., John Wiley&Sons, 1989.
P.A. Barnes, Thermochim. Acta, 114, 1987, 1.
D. Giron, J. Pharm. Biochem. Anal., 40,1986,755.
D. Giron, Acta Pharm. Jugosl., 40,1990, 95.
G. Bettinetti, Farmaco, 47 ,1992, 681.
A.F. Barnes, M. J. Hardy and T.J. Lever, J. Therm. Anal., 40, 1993, 499.
D. Giron, Thermal Analysis of Drugs and Drug Products, in Encyclopedia of Pharmaceutical Technology, 1995, vol. 15, p.1-79, Swarbrick, J. and Boylan, J.C., eds, Marcel Dekker.
P.H. Willcoks, Thermochim. Acta, 256, 1995, 1.
T. Wadsten, J. Therm. Anal., 47 ,1996, 525.
D. Giron, C. Goldbronn, Use of DSC an TG for the identification and quantification of the dosage form, J. Therm. Anal. Calorim., 48,1997,473.
D. Giron, J. Therm. Anal. Calorim., 56,1999,1285.
D. Giron, Am. Pharm. Rev., 3, 2000, 3 and 3, 2000, 43.
T. Ozawa, Thermochim. Acta, 355 ,,2000, 35.
S.Z.D.Cheng, C. Y. Li, B.H. Calhoun, L. Zhu and W.W. Zhou, Thermochim. Acta, 2000, 355, 59.
Giron, D.; Grant, D. J. W. in Handbook of Pharmaceutical Salts, ‘Properties, Selection and Use’,. P. H. Stahl,P.H; Wermuth, C.G. Eds, IUPAC, Wiley-Verlag Helvetica Chimica Acta, Zürich, 2002, Ch. 3 p.42-81
Burger, A. and Ramberger, R., “On the polymorphism of pharmaceuticals and other molecular crystals. I. Theory of thermodynamic rules, Mikrochim. Acta [Wienn] , 1979, II, 259.
Giron, D., Thermal Analysis and Calorimetric Methods in the Characterization of Polymorphs and Solvates, Thermochim. Acta, 1995, 248,1.
Giron, D., J. Therm. Anal. Cal., 2001, 64, 37.
Giron, D.; Garnier,S.; Mutz, M. J. Therm. Anal. Cal., 2004, 77, 709.
D. Giron, M. Draghi, C.Goldbronn, S. Pfeffer and P. Piechon, J. Thermal Anal., 49 (1997) 913.
D. Giron, C. Goldbronn, Place of DSC purity analysis in pharmaceutical development, J. Therm. Anal., 1995, 44, 217.
D. Giron, C. Goldbronn, P. Piechon, Thermal Analysis methods for pharrmacopieal materials, J. Pharm. Biomed. Anal., 1989, 7, 1421.
Hancock, B.C. and Zografi, G., (1997), “Characteristics and significance of the amorphous state in pharmaceutical systems”, J. Pharm. Sci, 1997, 86, 1-12 and Hancock, B.C; Shamblin, S.L. Thermochim. Acta, 2001, 380, 95-107
Yu, L., (2001), “Amorphous pharmaceutical solids: preparation, characterization and stabilization”, Adv.. Drug Deliv. Rev., 2001, 48, 27-42.
Gaisford, S. Stability assessment of pharmaceuticals and biopharmaceuticals by isothermal microcalorimetry. Current Pharmaceutical Biotechnology, 2005, 6, 181-191.
D. Giron, P.Remy, S. Thomas and E. Vilette, J. Thermal Anal., 48, 1997, 465.
Garnier,S.; Giron,D.; Mutz, M., “Study of crystallization of drug substances under solvent vapour atmosphere by microcalorimetry”, PhandTA7, Innsbruck, september 2003
Thermometric, Newletters and Application Notes. TAMIII, 48 channels. Sweden.
This website uses cookies to enable, optimise and analyse site operations, as well as to provide personalised content and allow you to connect to social media. By clicking "I agree" you consent to the use of cookies for non-essential functions and the related processing of personal data. You can adjust your cookie and associated data processing preferences at any time via our "Cookie Settings". Please view our Cookie Policy to learn more about the use of cookies on our website.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as ”Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these different types of cookies. But opting out of some of these cookies may have an effect on your browsing experience. You can adjust the available sliders to ‘Enabled’ or ‘Disabled’, then click ‘Save and Accept’. View our Cookie Policy page.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Cookie
Description
cookielawinfo-checkbox-advertising-targeting
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID
This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged
This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.
Performance cookies are includes cookies that deliver enhanced functionalities of the website, such as caching. These cookies do not store any personal information.
Cookie
Description
cf_ob_info
This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob
This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only
This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush
This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db
This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC
This cookie is set by Youtube and is used to track the views of embedded videos.
Analytics cookies collect information about your use of the content, and in combination with previously collected information, are used to measure, understand, and report on your usage of this website.
Cookie
Description
bcookie
This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS
This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang
This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc
This cookie is set by LinkedIn and used for routing.
lissc
This cookie is set by LinkedIn share Buttons and ad tags.
vuid
We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId
This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule
This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session
This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues
This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga
This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat
This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid
This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.
Advertising and targeting cookies help us provide our visitors with relevant ads and marketing campaigns.
Cookie
Description
advanced_ads_browser_width
This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions
This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info
This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer
This cookie is set by Advanced Ads and sets the referrer URL.
bscookie
This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE
This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr
This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory
This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE
This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.